Juliane Gust
Seattle Children's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Juliane Gust as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:26 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03638167 · EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsSeattle Children's Hospital · completed · Central Nervous System Tumor, Pediatric, Glioma, Ependymoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated NeurotoxicityR37CA275954 · NCI · SEATTLE CHILDREN'S HOSPITAL · fiscal years 2023 to 2026 · $578,929 awarded in 2026Same name and institution; not confirmed by an ID
- Brain Tumor CAR T Mouse ModelR03NS135446 · NINDS · SEATTLE CHILDREN'S HOSPITAL · fiscal years 2024 to 2025 · $98,450 awarded in 2025Same name and institution; not confirmed by an ID
- Blood Brain Barrier Disruption during Chimeric Antigen Receptor (CAR) T cell therapyK08NS118138 · NINDS · SEATTLE CHILDREN'S HOSPITAL · fiscal years 2020 to 2024 · $157,140 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name in atypical teratoid rhabdoid tumour (at/rt), ranked by citations from NIH iCite, fetched 2026-11-12 10:26 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed